Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Lacey

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Research|November 20, 2016
PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1Alexandra Lacey, Aline Rodrigues-Hoffman, Stephen Safe
Journal of Burn Care & Research : Official Publication of the American Burn Association|April 27, 2021
A Fatal Case of Toxic Epidermal Necrolysis Combined With Vanishing Bile Duct Syndrome and Hemophagocytic LymphohistiocytosisJulian Wier, Alexandra Lacey, Haig Yenikomshian, et al.
Molecular Cancer Research : MCR|August 30, 2019
Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in RhabdomyosarcomaErik Hedrick, Kumaravel Mohankumar, Alexandra Lacey, et al.
Molecular Cancer Research : MCR|January 6, 2019
Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription FactorsRavi Kasiappan, Indira Jutooru, Kumaravel Mohankumar, et al.
Molecular Cancer Therapeutics|September 8, 2018
Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for RhabdomyosarcomaAlexandra Lacey, Erik Hedrick, Yating Cheng, et al.
Oncotarget|May 5, 2016
Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS)Alexandra Lacey, Erik Hedrick, Xi Li, et al.
Breast Cancer Research and Treatment|May 24, 2019
Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonistsErik Hedrick, Xi Li, Yating Cheng, et al.
The Annals of Thoracic Surgery|April 30, 2014
Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipientsBryan A Whitson, Peter Eckman, Forum Kamdar, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|May 29, 2026
Nutrition Interventions in Older Adult Burn Patients: The Stratification of Albumin LevelMarah Kays, Ashlyn Elftmann, Nicholas Larson, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|April 23, 2025
Time to Thrombolytics and Tissue Salvage: Assessing Response Following Severe Frostbite InjuryRachel M Nygaard, Emily Colonna, Rediat A Tilahun, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Research|November 20, 2016
PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1Alexandra Lacey, Aline Rodrigues-Hoffman, Stephen Safe
Journal of Burn Care & Research : Official Publication of the American Burn Association|April 27, 2021
A Fatal Case of Toxic Epidermal Necrolysis Combined With Vanishing Bile Duct Syndrome and Hemophagocytic LymphohistiocytosisJulian Wier, Alexandra Lacey, Haig Yenikomshian, et al.
Molecular Cancer Research : MCR|August 30, 2019
Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in RhabdomyosarcomaErik Hedrick, Kumaravel Mohankumar, Alexandra Lacey, et al.
Molecular Cancer Research : MCR|January 6, 2019
Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription FactorsRavi Kasiappan, Indira Jutooru, Kumaravel Mohankumar, et al.
Molecular Cancer Therapeutics|September 8, 2018
Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for RhabdomyosarcomaAlexandra Lacey, Erik Hedrick, Yating Cheng, et al.
Oncotarget|May 5, 2016
Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS)Alexandra Lacey, Erik Hedrick, Xi Li, et al.
Breast Cancer Research and Treatment|May 24, 2019
Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonistsErik Hedrick, Xi Li, Yating Cheng, et al.
The Annals of Thoracic Surgery|April 30, 2014
Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipientsBryan A Whitson, Peter Eckman, Forum Kamdar, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|May 29, 2026
Nutrition Interventions in Older Adult Burn Patients: The Stratification of Albumin LevelMarah Kays, Ashlyn Elftmann, Nicholas Larson, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|April 23, 2025
Time to Thrombolytics and Tissue Salvage: Assessing Response Following Severe Frostbite InjuryRachel M Nygaard, Emily Colonna, Rediat A Tilahun, et al.
Pageof 2